Stockreport

DATROWAY® (datopotamab deruxtecan-dlnk) improved OS and PFS in TROPION-Breast02 [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF as 1st-line therapy for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option in TROPION-Breast02 AstraZeneca and Daiichi San [Read more]